Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Mar 15;99(6):1149–1152. doi: 10.1172/JCI119269

Integrins and vascular extracellular matrix assembly.

E Ruoslahti 1, E Engvall 1
PMCID: PMC507926  PMID: 9077520

Full Text

The Full Text of this article is available as a PDF (130.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assoian R. K., Marcantonio E. E. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J Clin Invest. 1996 Dec 1;98(11):2436–2439. doi: 10.1172/JCI119059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Border W. A., Noble N. A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994 Nov 10;331(19):1286–1292. doi: 10.1056/NEJM199411103311907. [DOI] [PubMed] [Google Scholar]
  3. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol. 1995 Aug;130(3):503–506. doi: 10.1083/jcb.130.3.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brooks P. C., Montgomery A. M., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., Cheresh D. A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994 Dec 30;79(7):1157–1164. doi: 10.1016/0092-8674(94)90007-8. [DOI] [PubMed] [Google Scholar]
  5. Brooks P. C., Strömblad S., Klemke R., Visscher D., Sarkar F. H., Cheresh D. A. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995 Oct;96(4):1815–1822. doi: 10.1172/JCI118227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Butcher E. C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991 Dec 20;67(6):1033–1036. doi: 10.1016/0092-8674(91)90279-8. [DOI] [PubMed] [Google Scholar]
  7. Carnemolla B., Neri D., Castellani P., Leprini A., Neri G., Pini A., Winter G., Zardi L. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int J Cancer. 1996 Nov 4;68(3):397–405. doi: 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  8. Choi E. T., Engel L., Callow A. D., Sun S., Trachtenberg J., Santoro S., Ryan U. S. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994 Jan;19(1):125–134. doi: 10.1016/s0741-5214(94)70127-x. [DOI] [PubMed] [Google Scholar]
  9. Conforti G., Dominguez-Jimenez C., Zanetti A., Gimbrone M. A., Jr, Cremona O., Marchisio P. C., Dejana E. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood. 1992 Jul 15;80(2):437–446. [PubMed] [Google Scholar]
  10. Curran M. E., Atkinson D. L., Ewart A. K., Morris C. A., Leppert M. F., Keating M. T. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell. 1993 Apr 9;73(1):159–168. doi: 10.1016/0092-8674(93)90168-p. [DOI] [PubMed] [Google Scholar]
  11. Delcommenne M., Streuli C. H. Control of integrin expression by extracellular matrix. J Biol Chem. 1995 Nov 10;270(45):26794–26801. doi: 10.1074/jbc.270.45.26794. [DOI] [PubMed] [Google Scholar]
  12. Engvall E., Wewer U. M. Domains of laminin. J Cell Biochem. 1996 Jun 15;61(4):493–501. doi: 10.1002/(SICI)1097-4644(19960616)61:4%3C493::AID-JCB2%3E3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  13. Friedlander M., Theesfeld C. L., Sugita M., Fruttiger M., Thomas M. A., Chang S., Cheresh D. A. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9764–9769. doi: 10.1073/pnas.93.18.9764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hammes H. P., Brownlee M., Jonczyk A., Sutter A., Preissner K. T. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med. 1996 May;2(5):529–533. doi: 10.1038/nm0596-529. [DOI] [PubMed] [Google Scholar]
  15. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  16. Hynes R. O. Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol. 1996 Dec 15;180(2):402–412. doi: 10.1006/dbio.1996.0314. [DOI] [PubMed] [Google Scholar]
  17. Hynes R. O., Wagner D. D. Genetic manipulation of vascular adhesion molecules in mice. J Clin Invest. 1996 Nov 15;98(10):2193–2195. doi: 10.1172/JCI119027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jucker M., Tian M., Norton D. D., Sherman C., Kusiak J. W. Laminin alpha 2 is a component of brain capillary basement membrane: reduced expression in dystrophic dy mice. Neuroscience. 1996 Apr;71(4):1153–1161. doi: 10.1016/0306-4522(95)00496-3. [DOI] [PubMed] [Google Scholar]
  19. Kratochwil K., Dziadek M., Löhler J., Harbers K., Jaenisch R. Normal epithelial branching morphogenesis in the absence of collagen I. Dev Biol. 1986 Oct;117(2):596–606. doi: 10.1016/0012-1606(86)90328-3. [DOI] [PubMed] [Google Scholar]
  20. Liaw L., Skinner M. P., Raines E. W., Ross R., Cheresh D. A., Schwartz S. M., Giachelli C. M. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995 Feb;95(2):713–724. doi: 10.1172/JCI117718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ljubimov A. V., Burgeson R. E., Butkowski R. J., Couchman J. R., Wu R. R., Ninomiya Y., Sado Y., Maguen E., Nesburn A. B., Kenney M. C. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci. 1996 May;37(6):997–1007. [PubMed] [Google Scholar]
  22. Noakes P. G., Miner J. H., Gautam M., Cunningham J. M., Sanes J. R., Merlie J. P. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet. 1995 Aug;10(4):400–406. doi: 10.1038/ng0895-400. [DOI] [PubMed] [Google Scholar]
  23. O'Reilly M. S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W. S., Flynn E., Birkhead J. R., Olsen B. R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997 Jan 24;88(2):277–285. doi: 10.1016/s0092-8674(00)81848-6. [DOI] [PubMed] [Google Scholar]
  24. Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 1996 Mar 28;380(6572):364–366. doi: 10.1038/380364a0. [DOI] [PubMed] [Google Scholar]
  25. Reinhardt D. P., Ono R. N., Sakai L. Y. Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem. 1997 Jan 10;272(2):1231–1236. doi: 10.1074/jbc.272.2.1231. [DOI] [PubMed] [Google Scholar]
  26. Ruggeri Z. M. von Willebrand factor. J Clin Invest. 1997 Feb 15;99(4):559–564. doi: 10.1172/JCI119195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697–715. doi: 10.1146/annurev.cellbio.12.1.697. [DOI] [PubMed] [Google Scholar]
  28. Seiffert D., Crain K., Wagner N. V., Loskutoff D. J. Vitronectin gene expression in vivo. Evidence for extrahepatic synthesis and acute phase regulation. J Biol Chem. 1994 Aug 5;269(31):19836–19842. [PubMed] [Google Scholar]
  29. Tryggvason K. Molecular properties and diseases of collagens. Kidney Int Suppl. 1995 Jun;49:S24–S28. [PubMed] [Google Scholar]
  30. Wolf Y. G., Rasmussen L. M., Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994 Mar;93(3):1172–1178. doi: 10.1172/JCI117070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wu C., Hughes P. E., Ginsberg M. H., McDonald J. A. Identification of a new biological function for the integrin alpha v beta 3: initiation of fibronectin matrix assembly. Cell Adhes Commun. 1996 Sep;4(3):149–158. doi: 10.3109/15419069609014219. [DOI] [PubMed] [Google Scholar]
  32. Yao L. Y., Moody C., Schönherr E., Wight T. N., Sandell L. J. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 1994 Apr;14(3):213–225. doi: 10.1016/0945-053x(94)90185-6. [DOI] [PubMed] [Google Scholar]
  33. Zhang Z., Vuori K., Reed J. C., Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6161–6165. doi: 10.1073/pnas.92.13.6161. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES